Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Talen Energy Corporation TLN |
Rubric Capital Management LP | 6,123,500 13.320% |
-5,245,114![]() (-46.14%) |
Filing History |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,350,000 7.290% |
1,100,000![]() (+88.00%) |
Filing History |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | QuidelOrtho Corporation QDEL |
Rubric Capital Management LP | 5,550,000 8.250% |
1,350,000![]() (+32.14%) |
Filing History |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | GoodRx Holdings, Inc. GDRX |
Rubric Capital Management LP | 5,804,628 5.570% |
1,124,600![]() (+24.03%) |
Filing History |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | Schrödinger, Inc. SDGR |
Rubric Capital Management LP | 5,000,000 7.850% |
1,314,497![]() (+35.67%) |
Filing History |
2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 4,205,129 4.710% |
-821,802![]() (-16.35%) |
Filing History |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | Seaport Entertainment Group Inc SEG |
Rubric Capital Management LP | 573,408 4.510% |
296,466![]() (+107.05%) |
Filing History |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | Golar LNG Limited GLNG |
Rubric Capital Management LP | 7,710,211 7.390% |
1,203,454![]() (+18.50%) |
Filing History |
2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
Rubric Capital Management LP | 5,258,754 4.560% |
-5,141,246![]() (-49.44%) |
Filing History |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | New Fortress Energy Inc. NFE |
Rubric Capital Management LP | 15,000,000 5.620% |
15,000,000![]() (New Position) |
Filing History |
2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Pediatrix Medical Group, Inc. MD |
Rubric Capital Management LP | 3,148,440 3.670% |
-5,126,560![]() (-61.95%) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Rubric Capital Management LP | 10,966,672 9.380% |
4,322,142![]() (+65.05%) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Coherus BioSciences, Inc. CHRS |
Rubric Capital Management LP | 10,400,000 9.030% |
10,400,000![]() (New Position) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Rubric Capital Management LP | 2,419,103 5.960% |
2,419,103![]() (New Position) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Schrödinger, Inc. SDGR |
Rubric Capital Management LP | 3,685,503 5.790% |
3,685,503![]() (New Position) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Seaport Entertainment Group Inc SEG |
Rubric Capital Management LP | 276,942 5.020% |
276,942![]() (New Position) |
Filing History |
2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Sutro Biopharma, Inc. STRO |
Rubric Capital Management LP | 0 0.000% |
-3,344,810![]() (Position Closed) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Talen Energy Corporation TLN |
Rubric Capital Management LP | 11,368,614 22.290% |
11,368,614![]() (New Position) |
Filing History |
2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Rubric Capital Management LP | 14,400,000 9.760% |
14,400,000![]() (New Position) |
Filing History |
2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | ANI Pharmaceuticals, Inc. ANIP |
Rubric Capital Management LP | 56,671 0.270% |
-1,068,329![]() (-94.96%) |
Filing History |